Quest LaboratoriesNSE:QUESTLAB -1.56%44 1-Year ROIIC % is 11.38 as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 8 warning signs investors should review. Among 968 Drug Manufacturers companies, Quest Laboratories ranks better than 59.71% on this metric.
1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
Quest Laboratories's 1-Year ROIIC % for the quarter that ended in Mar. 2026 was 11.38%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Quest Laboratories's 1-Year ROIIC % or its related term are showing as below:
NSE:QUESTLAB's 1-Year ROIIC % is ranked better than 59.71% of 968
companies
in the Drug Manufacturers industry
Industry Median: 1.315
vs NSE:QUESTLAB: 11.38
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Quest Laboratories 1-Year ROIIC % Related Terms
Quest Laboratories 1-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Quest Laboratories's 1-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QUESTLAB vs LLY, JNJ, ABBV: 1-Year ROIIC % Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories 1-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's 1-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Quest Laboratories (NSE:QUESTLAB) has a 1-Year ROIIC % of 11.38 as of Mar. 2026. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Quest Laboratories and its competitors. According to the industry distribution chart, Quest Laboratories ranks #390 out of 968 companies in the Drug Manufacturers industry, placing it in the top 40.3%.
Is Quest Laboratories' 1-Year ROIIC % too high?
Quest Laboratories' current 1-Year ROIIC % is 11.38. The Drug Manufacturers industry median 1-Year ROIIC % is 1.32. Quest Laboratories' value of 11.38 is 765.4% above this industry median. Based on the distribution chart, Quest Laboratories ranks #390 out of 968 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' 1-Year ROIIC % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #390 out of 968 companies for 1-Year ROIIC %. This puts Quest Laboratories in the upper half of its industry. The industry median 1-Year ROIIC % is 1.32. Quest Laboratories' value of 11.38 is 765.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Drug Manufacturers company?
The median 1-Year ROIIC % among Drug Manufacturers companies is 1.32, based on 968 companies in the industry. Companies in the top quartile (top 25%) have a 1-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest Laboratories's current 1-Year ROIIC % of 11.38 is 765.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Quest Laboratories and its competitors. For the Drug Manufacturers industry, the median 1-Year ROIIC % is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current 1-Year ROIIC % is 11.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current 1-Year ROIIC % of 11.38. The current 1-Year ROIIC % is 11.38 and 765.4% above the Drug Manufacturers industry median of 1.32. Quest Laboratories' overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current 1-Year ROIIC % is 11.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score
Get the complete analysis for NSE:QUESTLAB
1-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 